Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Non Operating Income (2016 - 2025)

Wave Life Sciences' Non Operating Income history spans 11 years, with the latest figure at $3.3 million for Q4 2025.

  • For Q4 2025, Non Operating Income rose 184.81% year-over-year to $3.3 million; the TTM value through Dec 2025 reached $6.5 million, up 1081.16%, while the annual FY2025 figure was $11.0 million, 240.5% up from the prior year.
  • Non Operating Income reached $3.3 million in Q4 2025 per WVE's latest filing, up from $324000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $8.5 million in Q4 2023 to a low of -$3.9 million in Q4 2024.
  • Average Non Operating Income over 5 years is $1.2 million, with a median of $870000.0 recorded in 2021.
  • Peak YoY movement for Non Operating Income: skyrocketed 928.57% in 2023, then crashed 355.56% in 2025.
  • A 5-year view of Non Operating Income shows it stood at $1.1 million in 2021, then plummeted by 192.42% to -$1.0 million in 2022, then skyrocketed by 921.43% to $8.5 million in 2023, then plummeted by 145.56% to -$3.9 million in 2024, then surged by 184.81% to $3.3 million in 2025.
  • Per Business Quant, the three most recent readings for WVE's Non Operating Income are $3.3 million (Q4 2025), $324000.0 (Q3 2025), and -$82000.0 (Q2 2025).